5:43 PM
 | 
Jul 26, 2013
 |  BC Extra  |  Company News

CHMP backs Boehringer's afatinib

EMA's CHMP on Friday backed approval of an MAA from Boehringer Ingelheim GmbH (Ingelheim, Germany) for...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >